DocGo Inc. (DCGO)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$322.2M$616.6M$624.3M$440.5M$318.7M$94.1M
Research & development$13.6M$11.6M$10.9M$5.4M$3.3M$1.2M
Operating expenses$500.2M$587.9M$609.2M$418.7M$303.4M$108.8M
Operating income−$178.0M$28.7M$15.1M$21.8M$15.4M−$14.8M
EBITDAderived−$162.4M$44.6M$31.5M$32.4M$17.7M−$9.3M
Net income−$182.4M$20.0M$6.9M$34.6M$23.7M−$14.8M
Basic EPSper diluted share-$1.84$0.20$0.07$0.34$0.30-$0.25
Diluted EPSper diluted share-$1.84$0.18$0.06$0.34$0.25-$0.25

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys6$116.7K disclosed value
Sells (SEC code S)3$189.5K disclosed value
9 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 15, 2025Form 4Tendler Ely DGeneral Counsel and SecretarySellCommon Stock16.9K$0.91$15.3K258.8K
May 23, 2025Form 4Burdiek Michael JDirectorBuyCommon Stock10.0K$1.33$13.3K641.6K
May 15, 2025Form 4Burdiek Michael JDirectorBuyCommon Stock15.0K$1.43$21.4K631.6K
May 14, 2025Form 4Klasko Stephen K. M.D.DirectorBuyCommon Stock15.0K$1.49$22.4K15.0K
May 14, 2025Form 4Sugrue StephenChief Compliance OfficerBuyCommon Stock10.0K$1.44$14.4K357.3K